246
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

Formulation of sage essential oil (Salvia officinalis, L.) monoterpenes into chitosan hydrogels and permeation study with GC-MS analysis

, , , , , & show all
Pages 1080-1088 | Received 10 Mar 2014, Accepted 18 May 2014, Published online: 16 Jun 2014

References

  • Vitková Z, Herdová P, Kodadová A, et al. Formulácia gélov s obsahom šalvie lekárskej [Formulation of salvia-containing gels]. Česka Slov Farm 2012;61:169–71
  • Bouaziz M, Yangui T, Sayadi S, Dhouib A. Disinfectant properties of essential oils from Salvia officinalis L. cultivated in Tunisia. Food Chem Toxicol 2009;47:2755–60
  • Mayer B, Baggio CH, Freitas CS, et al. Gastroprotective constituents of Salvia officinalis L. Fitoterapia 2009;80:421–6
  • Yudianti R, Karina M, Sakamoto M, Azuma J-I. Effects of salts on rheological behaviour of salvia hydrogels. Macromol Res 2009;17:332–8
  • Baricevic D, Sosa S, Della Loggia R, et al. Topical anti-inflammatory activity of Salvia officinalis L. leaves: the relevance of ursolic acid. J Ethnopharmacol 2001;75:125–32
  • Jančovičová A. Šalvia lekárska, Salvia officinalis. Lekárn listy 2004;6:37
  • Mockute D, Nivinskiene O, Bernotiene G, Butkiene R. The cis-thujone chemotype of Salvia officinalis, L. essential oil. CHEMIJA 2003;14:216–20
  • Bernotiene G, Nivinskiene O, Butkiene R, Mockute D. Essential oil composition in sage (Salvia officinalis, L.). CHEMIJA 2007;18:38–43
  • O’Donnell KP, Williams III RO. Nanoparticle systems for oral drug delivery to the colon. Int J Nanotechnol 2011;8:4–20
  • Bosselmann S, Williams III RO. Has nanotechnology led to improved therapeutic outcomes? Drug Dev Ind Pharm 2012;38:158–70
  • Watts AB, Wang YB, Johnston KP, Williams III RO. Respirable low-density microparticles formed in situ from aerosolized brittle matrices. Pharm Res 2013;30:813–25
  • Vaghani SS, Patel MM. pH-sensitive hydrogels based on semi-interpenetrating network (semi-IPN) of chitosan and polyvinyl pyrrolidone for clarithromycin release. Drug Dev Ind Pharm 2011;37:1160–9
  • Mohamed NA, Fahmy MM. Synthesis and antimicrobial activity of some novel cross-linked chitosan hydrogels. Int J Mol Sci 2012;13:11194–209
  • Sakloetsakun D, Iqbal J, Millotti G, et al. Thiolated chitosans: influence of various sulfhydryl ligands on permeation-enhancing and P-gp inhibitory properties. Drug Dev Ind Pharm 2011;37:648–55
  • Maestrelli F, Cirri M, Mennini N, et al. Influence of cross-linking agent type and chitosan content on the performance of pectinate-chitosan beads aimed for colon-specific drug delivery. Drug Dev Ind Pharm 2012;38:1142–51
  • Tuntikulwattana S, Sinchaipanid N, Ketjinda W, et al. Fabrication of chitosan–polyacrylic acid complexes as polymeric osmogents for swellable micro/nanoporous osmotic pumps. Drug Dev Ind Pharm 2011;37:926–33
  • Brück WM, Slater JW, Carney BF. Chitin and chitosan from marine organisms. In: Se-Kwon K, ed. Chitin, chitosan, oligosaccharides and their derivatives. New York: CRC Press, Taylor and Francis Group; 2010:11–23
  • El-Far M, Elshal M, Refaat M, El-Sherbiny IM. Antitumor activity and antioxidant role of a novel water-soluble carboxymethyl chitosan-based copolymer. Drug Dev Ind Pharm 2011;37:1481–90
  • Chen W, Fan D, Meng L, et al. Enhancing effects of chitosan and chitosan hydrochloride on intestinal absorption of berberine in rats. Drug Dev Ind Pharm 2012;38:104–10
  • Chung YC, Chen CY. Antibacterial characteristics and activity of acid-soluble chitosan. Bioresour Technol 2008;99:2806–14
  • Park PJ, Je JY, Byun HG, et al. Antimicrobial activity of hetero-chitosans and their oligosaccharides with different molecular weights. J Microbiol Biotechnol 2004;14:317–23
  • Park PJ, Lee HK, Kim SK. Preparation of hetero-chitooligosaccharides and their antimicrobial activity on Vibrio parahemolyticus. J Microbiol Biotechnol 2004;14:41–7
  • Alsarra IA. Chitosan topical gel formulation in the management of burn wounds. Int J Biol Macromol 2009;45:16–21
  • Vitková Z, Oremusová J, Herdová P, Kodadová A. Release and rheological properties of topical drugs. Tenside Surfact Det 2013;50:39–44
  • Chalupová Z, Masteiková R, Savickas A. Farmaceutické hydrofilné gely [Pharmaceutical hydrophilic gels]. Česka Slov Farm 2005;54:55–8
  • Matušová D, Truplová E. Liečivá a prípravky na terapiu popálenín [Drugs and preparations for the treatment of burns]. Čes Slov Farm 2006;55:52
  • Herdová P, Vitková Z. Uplatnenie chitosanu v dermálnych polotuhých liekoch [Application of Chitosan in dermal semisolid drugs]. Derma 2010;10:7–9
  • Park D-M, Song Y-K, Jee J-P, et al. Development of chitosan-based ondansetron buccal delivery system for the treatment of emesis. Drug Dev Ind Pharm 2012;38:1077–83
  • Liang H, Yang Q, Deng L, et al. Phospholipid–Tween 80 mixed micelles as an intravenous delivery carrier for paclitaxel. Drug Dev Ind Pharm 2011;37:597–605
  • Chalabala M, Komárek P, Kopecký F, et al. Technologie léků [Technology of medicaments], 2nd ed. Praha: Galén; 1997:28–9
  • Tomko J. Farmakognózia, 2nd ed. Martin: Osveta; 1999:276–7, 299
  • Slovak pharmaceutical code 1, 1st ed. Bratislava: Herba, 1997:354
  • WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD index for caffeine. Available from: http://www.whocc.no/atc_ddd_index/?code=N06BC01 [last accessed 21 Nov 2013]
  • Lavríková L. Zelené zlato. Lekárnik 2009;14:52–3
  • US Food and Drug Administration. ICH harmonised tripartite guideline: validation of analytical procedures: text and methodology Q2(R1), Step 4 version; 2005

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.